35457010|t|Autophagy Signaling by Neural-Induced Human Adipose Tissue-Derived Stem Cell-Conditioned Medium during Rotenone-Induced Toxicity in SH-SY5Y Cells.
35457010|a|Rotenone (ROT) inhibits mitochondrial complex I, leading to reactive oxygen species formation, which causes neurodegeneration and alpha-synuclein (alpha-syn) aggregation and, consequently, Parkinson's disease. We previously found that a neurogenic differentiated human adipose tissue-derived stem cell-conditioned medium (NI-hADSC-CM) was protective against ROT-induced toxicity in SH-SY5Y cells. In the present study, ROT significantly decreased the phospho (p)-mTORC1/total (t)-mTOR, p-mTORC2/t-mTOR, and p-/t-ULK1 ratios and the ATG13 level by increasing the DEPTOR level and p-/t-AMPK ratio. Moreover, ROT increased the p-/t-Akt ratio and glycogen synthase kinase-3beta (GSK3beta) activity by decreasing the p-/t-ERK1/2 ratios and beclin-1 level. ROT also promoted the lipidation of LC3B-I to LC3B-II by inducing autophagosome formation in Triton X-100-soluble and -insoluble cell lysate fractions. Additionally, the levels of ATG3, 5, 7, and 12 were decreased, along with those of lysosomal LAMP1, LAMP2, and TFEB, leading to lysosomal dysfunction. However, NI-hADSC-CM treatment increased the p-mTORC1, p-mTORC2, p-ULK1, p-Akt, p-ERK1/2, ATG13, and beclin-1 levels and decreased the p-AMPK level and GSK3beta activity in response to ROT-induced toxicity. Additionally, NI-hADSC-CM restored the LC3B-I level, increased the p62 level, and normalized the ATG and lysosomal protein amounts to control levels. Autophagy array revealed that the secreted proteins in NI-hADSC-CM could be crucial in the neuroprotection. Taken together, our results showed that the neuroprotective effects of NI-hADSC-CM on the autophagy signaling pathways could alleviate the aggregation of alpha-syn in Parkinson's disease and other neurodegenerative disorders.
35457010	38	43	Human	Species	9606
35457010	103	111	Rotenone	Chemical	MESH:D012402
35457010	120	128	Toxicity	Disease	MESH:D064420
35457010	132	139	SH-SY5Y	CellLine	CVCL:0019
35457010	147	155	Rotenone	Chemical	MESH:D012402
35457010	157	160	ROT	Chemical	MESH:D012402
35457010	207	230	reactive oxygen species	Chemical	MESH:D017382
35457010	255	272	neurodegeneration	Disease	MESH:D019636
35457010	277	292	alpha-synuclein	Gene	6622
35457010	294	303	alpha-syn	Gene	6622
35457010	336	355	Parkinson's disease	Disease	MESH:D010300
35457010	410	415	human	Species	9606
35457010	469	480	NI-hADSC-CM	Chemical	-
35457010	505	508	ROT	Chemical	MESH:D012402
35457010	517	525	toxicity	Disease	MESH:D064420
35457010	529	536	SH-SY5Y	CellLine	CVCL:0019
35457010	566	569	ROT	Chemical	MESH:D012402
35457010	627	631	mTOR	Gene	2475
35457010	644	648	mTOR	Gene	2475
35457010	659	663	ULK1	Gene	8408
35457010	679	684	ATG13	Gene	9776
35457010	709	715	DEPTOR	Gene	64798
35457010	731	735	AMPK	Gene	5562
35457010	753	756	ROT	Chemical	MESH:D012402
35457010	776	779	Akt	Gene	207
35457010	790	820	glycogen synthase kinase-3beta	Gene	2932
35457010	822	830	GSK3beta	Gene	2932
35457010	864	870	ERK1/2	Gene	5595;5594
35457010	882	890	beclin-1	Gene	8678
35457010	898	901	ROT	Chemical	MESH:D012402
35457010	934	939	LC3B-	Gene	81631
35457010	991	1003	Triton X-100	Chemical	MESH:D017830
35457010	1078	1096	ATG3, 5, 7, and 12	Gene	64422;9474;10533;9140
35457010	1143	1148	LAMP1	Gene	3916
35457010	1150	1155	LAMP2	Gene	3920
35457010	1161	1165	TFEB	Gene	7942
35457010	1178	1199	lysosomal dysfunction	Disease	MESH:D016464
35457010	1210	1221	NI-hADSC-CM	Chemical	-
35457010	1268	1272	ULK1	Gene	8408
35457010	1276	1279	Akt	Gene	207
35457010	1283	1289	ERK1/2	Gene	5595;5594
35457010	1291	1296	ATG13	Gene	9776
35457010	1302	1310	beclin-1	Gene	8678
35457010	1338	1342	AMPK	Gene	5562
35457010	1353	1361	GSK3beta	Gene	2932
35457010	1386	1389	ROT	Chemical	MESH:D012402
35457010	1398	1406	toxicity	Disease	MESH:D064420
35457010	1422	1433	NI-hADSC-CM	Chemical	-
35457010	1447	1451	LC3B	Gene	81631
35457010	1475	1478	p62	Gene	23636
35457010	1613	1624	NI-hADSC-CM	Chemical	-
35457010	1737	1748	NI-hADSC-CM	Chemical	-
35457010	1820	1829	alpha-syn	Gene	6622
35457010	1833	1852	Parkinson's disease	Disease	MESH:D010300
35457010	1863	1890	neurodegenerative disorders	Disease	MESH:D019636
35457010	Positive_Correlation	MESH:D012402	81631
35457010	Positive_Correlation	MESH:D012402	MESH:D016464
35457010	Association	MESH:D016464	9474
35457010	Association	MESH:D012402	MESH:D017830
35457010	Negative_Correlation	MESH:D012402	9474
35457010	Positive_Correlation	MESH:D012402	5562
35457010	Positive_Correlation	MESH:D012402	207
35457010	Association	MESH:D010300	6622
35457010	Positive_Correlation	MESH:D012402	2932
35457010	Positive_Correlation	MESH:D012402	6622
35457010	Positive_Correlation	MESH:D012402	MESH:D019636
35457010	Negative_Correlation	MESH:D012402	2475
35457010	Association	MESH:D016464	9140
35457010	Association	MESH:D016464	7942
35457010	Positive_Correlation	MESH:D012402	MESH:D010300
35457010	Association	MESH:D016464	64422
35457010	Association	MESH:D016464	10533
35457010	Negative_Correlation	MESH:D012402	8408
35457010	Negative_Correlation	MESH:D012402	10533
35457010	Negative_Correlation	MESH:D012402	64422
35457010	Negative_Correlation	MESH:D012402	9776
35457010	Positive_Correlation	MESH:D012402	MESH:D064420
35457010	Negative_Correlation	MESH:D012402	5594
35457010	Negative_Correlation	MESH:D012402	9140
35457010	Association	MESH:D017382	MESH:D019636
35457010	Negative_Correlation	MESH:D012402	8678
35457010	Positive_Correlation	MESH:D012402	MESH:D017382
35457010	Association	MESH:D019636	6622
35457010	Positive_Correlation	MESH:D012402	64798
35457010	Negative_Correlation	MESH:D012402	5595

